Was the Main Paper from VART Study “Practice” for a Grad Student?

“The VART study is essentially a failed study,” divulges an industry insider. Chiba University’s VART study investigated the cardiorenal protective effects of Novartis Pharma’s angiotensin receptor blocker Diovan (valsartan) and the calcium channel blocker amlodipine in Japanese hypertensive patients. In...read more